Clinical Trials Browser

Lymphoma, Follicular × ibrutinib × 30 days × Clear all

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT01804686 2026-03-12

CAN3001

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT03198026 2026-02-19

Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas

Phase 2 Active not recruiting

30 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Clinical Trials

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

CAN3001

Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas